Progress Toward the ElusivePseudomonas aeruginosaVaccine-Reference-Cited by-同舟云学术

Progress Toward the ElusivePseudomonas aeruginosaVaccine

Published:2018-12 Issue:8 Volume:19 Page:757-768
ISSN:1096-2964
Container-title:Surgical Infections
language:en
Short-container-title:Surgical Infections

Author:

Merakou Christina¹²,Schaefers Matthew M.¹²,Priebe Gregory P.¹²³

Affiliation:

1. Division of Critical Care Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts.

2. Department of Anaesthesia, Harvard Medical School, Boston, Massachusetts.

3. Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Microbiology (medical),Surgery

Link

https://www.liebertpub.com/doi/pdf/10.1089/sur.2018.233

Reference106 articles.

1. The Regulatory Network of Pseudomonas aeruginosa

2. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen

3. Recent developments for Pseudomonas vaccines

4. Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010

5. Global Prospective Epidemiologic and Surveillance Study of Ventilator-Associated Pneumonia due to Pseudomonas aeruginosa*

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical Synthesis and Antigenicity Evaluation of an Aminoglycoside Trisaccharide Repeating Unit of Pseudomonas aeruginosa Serotype O5 O-Antigen Containing a Rare Dimeric-ManpN3NA;Journal of the American Chemical Society;2024-07-01

2. Recent trends and challenges to overcome Pseudomonas aeruginosa infections;Expert Opinion on Therapeutic Patents;2024-05-03

3. Ten golden rules for optimal antibiotic use in hospitals: based on the publication statement of the International Network Group of the World Antimicrobial Resistance;The Ukrainian Journal of Clinical Surgery;2024-04-20

4. Development of a nano-emulsion based multivalent protein subunit vaccine against Pseudomonas aeruginosa;Frontiers in Immunology;2024-04-18

5. Enhanced protective efficacy of an OprF/PcrV bivalent DNA vaccine against Pseudomonas aeruginosa using a hydrogel delivery system;Biomedicine & Pharmacotherapy;2024-03